Received Nov 21, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| PNC20 | PNEUMO (PREVNAR20) | PFIZER\WYETH | 1 | MA2506 | OT |
possible cellulitis; reaction with erythema and swelling which spread to involve the whole left upper arm; reaction with erythema and swelling which spread to involve the whole left upper arm; reaction with erythema and swelling which spread to involve the whole left upper arm; reaction with erythema and swelling which spread to involve the whole left upper arm; The initial case was missing the following minimum criteria: (No adverse effect). Upon receipt of follow-up information on (12Nov2025), this case now contains all required information to be considered valid. This is a spontaneous report received from a Consumer or other non HCP. A 57-year-old female patient received pneumococcal 20-val conj vac (dipht CRM197 protein) (PREVNAR 20), on 16Oct2025 as dose 1, 0.5 ml single (Lot number: MA2506, Expiration Date: 31Oct2026) at the age of 57 years intramuscular for immunisation. The patient's relevant medical history included: "Sleep Apnea", start date: Jun2024 (unspecified if ongoing); "Overweight" (unspecified if ongoing). Concomitant medication(s) included: WEGOVY taken for overweight. The following information was reported: VACCINATION SITE CELLULITIS (medically significant) with onset 18Oct2025, outcome "recovering", described as "possible cellulitis"; VACCINATION SITE ERYTHEMA (non-serious), VACCINATION SITE SWELLING (non-serious), ERYTHEMA (non-serious), PERIPHERAL SWELLING (non-serious) all with onset 18Oct2025, outcome "recovering" and all described as "reaction with erythema and swelling which spread to involve the whole left upper arm". Therapeutic measures were taken as a result of vaccination site cellulitis, vaccination site erythema, vaccination site swelling, erythema, peripheral swelling. Treatment received for the adverse event included Keflex for possible cellulitis. On 30Oct2025, the patient still has residual redness. Causality for "possible cellulitis" and "reaction with erythema and swelling which spread to involve the whole left upper arm" was determined associated to device constituent of pneumococcal 20-val conj vac (dipht CRM197 protein).
Medical History/Concurrent Conditions: Overweight; Sleep apnea
WEGOVY